Péter Mátyus Selected Research

Amine Oxidase (Copper-Containing)

2/2021	Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats.
12/2020	Radiosynthesis and Preclinical Investigation of 11 C-Labelled 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanal Oxime ([11 C]SZV 1287).
1/2018	Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: Involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors.
1/2017	Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse.
6/2013	Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Péter Mátyus Research Topics

Disease

4	Neuralgia (Stump Neuralgia) 06/2021 - 01/2018
3	Hyperalgesia 06/2021 - 01/2017
2	Pain (Aches) 01/2018 - 01/2017
2	Neuroblastoma 01/2018 - 01/2014
2	Arthritis (Polyarthritis) 01/2018 - 01/2017
2	Inflammation (Inflammations) 01/2017 - 06/2013
2	Parkinson Disease (Parkinson's Disease) 02/2015 - 09/2012
2	Corneal Neovascularization 06/2013 - 07/2011
1	Hyperthermia 06/2021
1	Diabetes Mellitus 02/2021
1	Hypersensitivity (Allergy) 02/2021
1	Cold Hypersensitivity 02/2021
1	Hyperglycemia 02/2021
1	Diabetes Complications 02/2021
1	Metabolic Diseases (Metabolic Disease) 02/2021
1	Torsades de Pointes (Torsade de Pointes) 01/2021
1	Migraine Disorders (Migraine) 01/2019
1	Mononeuropathies (Mononeuritis Multiplex) 01/2018
1	Edema (Dropsy) 01/2018
1	Premature Cardiac Complexes (Extrasystoles) 07/2017
1	Wounds and Injuries (Trauma) 01/2014
1	Corneal Injuries 06/2013
1	Carcinogenesis 05/2013
1	Colorectal Neoplasms (Colorectal Cancer) 05/2013
1	Neoplasms (Cancer) 05/2013
1	Movement Disorders (Movement Disorder) 01/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2012
1	Insulin Resistance 12/2010
1	Thrombosis (Thrombus) 12/2009
1	Brain Injuries (Brain Injury) 10/2006
1	Ischemia 10/2006
1	Infarction (Infarctions) 10/2006
1	Cardiac Arrhythmias (Arrythmia) 01/2004
1	Atrial Fibrillation 01/2004

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 06/2021 - 09/2012
5	Amine Oxidase (Copper-Containing)IBA 02/2021 - 06/2013
4	Analgesics (Analgesic Drugs)IBA 06/2021 - 01/2017
3	human AOC3 proteinIBA 06/2013 - 12/2010
2	Insulin (Novolin)FDA Link 02/2021 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 02/2021 - 06/2013
2	EnzymesIBA 02/2021 - 06/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2010
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 01/2017
2	3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oximeIBA 01/2017 - 06/2013
2	N'-(2-phenylallyl)hydrazineIBA 06/2013 - 06/2013
1	Protons (Proton)IBA 06/2021
1	CalciumIBA 06/2021
1	AminesIBA 02/2021
1	Oxidoreductases (Dehydrogenase)IBA 02/2021
1	FructosamineIBA 02/2021
1	Retinaldehyde (Retinal)IBA 02/2021
1	CreatinineIBA 02/2021
1	Streptozocin (Streptozotocin)FDA Link 02/2021
1	Tandem Pore Domain Potassium Channels (Tandem Pore Domain Potassium Channel)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2018
1	AcetylcholinesteraseIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	resiniferatoxinIBA 01/2018
1	1,3-cyclohexanedioneIBA 01/2018
1	AnkyrinsIBA 01/2018
1	Mexiletine (Mexitil)FDA LinkGeneric 07/2017
1	Chemotactic FactorsIBA 01/2017
1	Monoamine Oxidase (MAO)IBA 02/2015
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2014
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 06/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2013
1	Cholecalciferol (Vitamin D3)FDA Link 05/2013
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2013
1	Vitamin D3 24-HydroxylaseIBA 05/2013
1	Neuroprotective AgentsIBA 09/2012
1	Bevacizumab (Avastin)FDA Link 07/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011
1	benzylamineIBA 12/2010
1	Hypnotics and Sedatives (Sedatives)IBA 12/2009
1	SolutionsIBA 10/2006
1	triphenyltetrazoliumIBA 10/2006
1	FormazansIBA 10/2006
1	PotassiumIBA 01/2004
1	6- cyano- 4- (N- ethylsulfonyl- N- methylamino)- 3- hydroxy- 2,2- dimethylchromaneIBA 01/2004
1	Anti-Arrhythmia AgentsIBA 01/2004
1	L 735821IBA 01/2004
1	HMR 1556IBA 01/2004

Therapy/Procedure

2	Injections 02/2021 - 01/2018
2	Therapeutics 02/2015 - 06/2013
1	Ligation 01/2018
1	Drug Therapy (Chemotherapy) 01/2004